Percutaneous ablation of malignant and locally aggressive solid tumors in pediatric patients

Image‐guided percutaneous ablation is an accepted treatment modality for common adult cancers. Unfortunately, its use in patients younger than 18 years is rare. This retrospective review presents our series of pediatric patients treated with ablation at our institution. From January 2002 to December...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric blood & cancer 2022-12, Vol.69 (12), p.e29951-n/a
Main Authors: Hawari, Mohamad El, Moussa, Amgad, Erinjeri, Joseph P., Ziv, Etay, Maybody, Majid, Santos Martin, Ernesto G., Solomon, Stephen B., Gonzalez‐Aguirre, Adrian J.
Format: Article
Language:English
Subjects:
Ablation
Hematology
Oncology
Patients
Pediatrics
percutaneous ablation
radiology
Solid tumors
Survival
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Image‐guided percutaneous ablation is an accepted treatment modality for common adult cancers. Unfortunately, its use in patients younger than 18 years is rare. This retrospective review presents our series of pediatric patients treated with ablation at our institution. From January 2002 to December 2021, a total of 14 patients (17 lesions) younger than 18 years were treated with percutaneous image‐guided ablation. Estimated overall survival at 5 years was 58%; median survival of this group was not reached. Estimated local tumor progression‐free survival at 5 years was 62%. One major complication was recorded.
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.29951